Dual dependence on BCL2 and MCL1 in T-cell prolymphocytic leukemia

Treatment of relapsed refractory T-PLL with venetoclax monotherapy results in only transient and minor clinical responses.In vitro analyses pre- and postvenetoclax indicate dual dependence on BCL2 and MCL1; combined BCL2 and MCL1 inhibition are synergistic.